Sánchez, Daniela <br/><br/>
Impact of genotypic diversity on selection of subtype-specific drug resistance profiles during raltegravir-based therapy in individuals infected with B and BF recombinant HIV-1 strains.  [electronic resource] 

 -  The Journal of antimicrobial chemotherapy  06 2020 
 - 1567-1574 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1460-2091 
<br/><br/><label>Standard No.: </label>10.1093/jac/dkaa042  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Drug Resistance, Viral--genetics<br/>Genotype<br/>HIV Infections--drug therapy<br/>HIV Integrase--genetics<br/>HIV-1--genetics<br/>Humans<br/>Mutation<br/>Phylogeny<br/>Raltegravir Potassium--therapeutic use